Atlas Trials

Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

Clinical trial NCT03201913 · COMPLETED

Trial details

NCT number
NCT03201913
Sponsor
TTC Oncology, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic ER+ Breast Cancer
Start date
2017-12-11
Primary completion
2019-12-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.